Skip to main content
. 2024 Nov 22;16(4):e70033. doi: 10.1002/dad2.70033

FIGURE 4.

FIGURE 4

Summary findings on the envisioned future role of tau‐PET in drug trials. (A) Circular bar plot showing proportions of respondents envisioning a role for tau‐PET for participant selection and measuring endpoints across different drug classes. (B) Bar plots showing proportions of respondents envisioning a role for tau‐PET for participant selection, monitoring and target engagement within four anti‐tau trial classes specifically. (C) Bar plots showing proportions of respondents envisioning a role for tau‐PET for participant selection, monitoring and target engagement within anti‐amyloid drug trials specifically. tau‐PET, tau positron emission tomography.